In addition, the authors found the covert duplication of reports on ondansetron was not easy to detect, because of lack of cross-referencing between papers, and reports containing duplicate findings were cited in eight reviews of the drug [REF].
Ondansetron is a generic drug and is available in many countries under many brand names [REF].